Methylobacteriaceae
Methylobacteriaceae
The Methylobacteriaceae is a family of Gram-negative bacteria within the order Rhizobiales. Members of this family are known for their ability to utilize methanol and other one-carbon compounds as their sole source of carbon and energy. This metabolic capability is due to the presence of the enzyme methanol dehydrogenase, which catalyzes the oxidation of methanol to formaldehyde.
Characteristics
Bacteria in the Methylobacteriaceae family are typically aerobic and motile, with some species exhibiting pink-pigmentation due to the presence of carotenoids. They are commonly found in a variety of environments, including soil, water, and on plant surfaces. The ability to colonize plant surfaces is facilitated by their production of biofilms, which protect the bacteria from environmental stresses and allow them to interact with the plant host.
Genera
The family Methylobacteriaceae includes several genera, with the most well-known being Methylobacterium. Other genera include Methylorubrum, Microvirga, and Methylopila. Each genus contains species with unique adaptations to their specific ecological niches.
Ecological Role
Methylobacteriaceae play a significant role in the carbon cycle by oxidizing methanol, a common byproduct of plant metabolism. This process not only helps in recycling carbon but also supports the growth of these bacteria in methanol-rich environments. Additionally, some members of this family are known to promote plant growth by producing phytohormones and facilitating nutrient uptake.
Applications
Due to their metabolic versatility, Methylobacteriaceae have potential applications in bioremediation and biotechnology. They can be used to degrade pollutants such as formaldehyde and methanol in contaminated environments. Furthermore, their ability to produce valuable compounds like vitamins and antioxidants makes them attractive for industrial applications.
Related pages
| Microbiology: Bacteria | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
